Biogen’s new Alzheimer’s treatment had ‘potentially the worst drug launch of all time,’ analyst says

A Wall Street analyst described the launch of Biogen’s new Alzheimer’s disease drug as 'potentially the worst drug launch of all time,' and others are also unimpressed.